A World Health Association project has been given permission by Moderna Inc. to use its Coronavirus vaccination.
to promote mRNA injections that would improve access and creation for underdeveloped countries.
South African biotechnology company Afrigen Biologics and Immunizations, which collaborates with the WHO,
According to Petro Terblanche, the director of Afrigen, the Moderna vaccination has been used in mouse studies to test the effectiveness of its own doses.
Since newer strains of the infection only cause milder illness, interest in coronavirus vaccinations has declined globally.
But many people live unvaccinated and defenceless against the potentially fatal disease in low- and middle-income countries like South Africa.